Skip to main content
. 2020 Sep 17;12(9):2652. doi: 10.3390/cancers12092652

Figure 5.

Figure 5

Account of clinical trials targeting CAFs or CAFs’ functions. The graph represents number of clinical trials (non-cumulative) targeting CAFs over time. Total number of clinical trials are indicated in orange (n = 175), ongoing clinical trials in blue (n = 135), failed or terminated or withdrawn trials in red (n = 37), and FDA-approved drugs in green. Arrows indicate the time period when the trial of the FDA-approved drug was published (n = 3)